Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia
Open Access
- 1 January 2010
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (5), 3035-3043
- https://doi.org/10.1074/jbc.m109.083899
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR−/− and apoE−/− miceJournal of Lipid Research, 2009
- FXR signaling in metabolic diseaseFEBS Letters, 2007
- Cooperative Interaction between Hepatocyte Nuclear Factor 4α and GATA Transcription Factors Regulates ATP-Binding Cassette Sterol Transporters ABCG5 and ABCG8Molecular and Cellular Biology, 2007
- FXR, a multipurpose nuclear receptorTrends in Biochemical Sciences, 2006
- Bile acids and cytokines inhibit the human cholesterol 7α-hydroxylase gene via the JNK/c-jun pathway in human liver cellsHepatology, 2006
- Farnesoid X receptor is essential for normal glucose homeostasisJCI Insight, 2006
- Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXRGenes & Development, 2004
- Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional ActivationJournal of Biological Chemistry, 2003
- The Farnesoid X-receptor Is an Essential Regulator of Cholesterol HomeostasisJournal of Biological Chemistry, 2003
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959